PATENT CLAIM ANALYSIS

Application Number: 15753552
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
A novel delivery system for drugs, and especially macromolecules such as proteins or oligonucleotides through biological membranes is provided, and specifically delivery of siRNA. The delivery system comprises conjugation of the macromolecule drug to a moiety that enables effective passage through the membranes. Respectively, novel compounds and pharmaceutical compositions are provided, utilizing said delivery system. In one aspect of the invention, the compounds may be utilized in medical practice, for example, in delivery of siRNA or antisense oligonucleotides across biological membranes for the treatment of medical disorders.

Claim (Index 41):
A method according to  claim 40 , wherein each of the flanking electron-withdrawing groups is selected from the group selected from carbonyl, ether, ester and fluorocarbon moieties.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 88.0
- Lexical Diversity: 1.66102
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15222559', '14872179', '14830799', '15691821', '14690499']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8321935111214607
- 35 USC 102 Novelty (BERT): 0.5729836383343307
- Combined Prediction Score: 0.8062725238427477
- Mean Citation Score: 441.934864
- Max Citation Score: 574.69934
- Similarity Product: 342.7904348206091

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test